A02114 Summary:

BILL NOA02114A
 
SAME ASSAME AS S06613
 
SPONSORDavila
 
COSPNSRStirpe, Hevesi, O'Donnell, Cruz, Ramos, Taylor, McDonald, Bendett, Slater, Brown K, Lemondes
 
MLTSPNSR
 
Add 921-b, Ed L
 
Authorizes schools to possess and administer FDA approved opioid reversal agents in emergency situations to negate or neutralize, in whole or in part, the pharmacological effects of an opioid in the human body.
Go to top    

A02114 Actions:

BILL NOA02114A
 
01/23/2023referred to education
04/27/2023amend (t) and recommit to education
04/27/2023print number 2114a
01/03/2024referred to education
Go to top

A02114 Committee Votes:

Go to top

A02114 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A02114 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         2114--A
 
                               2023-2024 Regular Sessions
 
                   IN ASSEMBLY
 
                                    January 23, 2023
                                       ___________
 
        Introduced by M. of A. DAVILA -- read once and referred to the Committee
          on  Education -- committee discharged, bill amended, ordered reprinted
          as amended and recommitted to said committee
 
        AN ACT to amend the education law, in relation to authorizing schools to
          possess and administer FDA approved opioid reversal agents in emergen-
          cy situations

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1. The education law is amended by adding a new section 921-b
     2  to read as follows:
     3    § 921-b. On-site FDA approved  opioid  reversal  agents.    1.  School
     4  districts, boards of cooperative educational services, county vocational
     5  education  and extension boards, charter schools, and non-public elemen-
     6  tary and secondary schools  in  this  state  may  provide  and  maintain
     7  on-site  in  each  instructional school facility all FDA approved opioid
     8  reversal agents in quantities and types deemed by the  commissioner,  in
     9  consultation  with  the commissioner of health, to be adequate to ensure
    10  ready and appropriate access for use during emergencies to  any  student
    11  or staff to negate or neutralize, in whole or in part, the pharmacologi-
    12  cal effects of an opioid in the human body.
    13    2. School districts, boards of cooperative educational services, coun-
    14  ty  vocational education and extension boards, charter schools, and non-
    15  public elementary and  secondary  schools  in  this  state,  any  person
    16  employed  by  any  such  entity,  or employed by a contractor of such an
    17  entity while performing services for the entity may administer  any  FDA
    18  approved opioid reversal agents in the event of an emergency.
    19    § 2. This act shall take effect on the one hundred twentieth day after
    20  it  shall have become a law. Effective immediately, the addition, amend-
    21  ment and/or repeal of any rule or regulation necessary for the implemen-
    22  tation of this act on its effective date are authorized to be  made  and
    23  completed on or before such effective date.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02445-02-3
Go to top